Genetic background of mitral valve prolapse.


Journal

Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007

Informations de publication

Date de publication:
12 Mar 2022
Historique:
received: 02 12 2021
revised: 09 01 2022
accepted: 25 01 2022
entrez: 29 3 2022
pubmed: 30 3 2022
medline: 19 4 2022
Statut: ppublish

Résumé

Mitral valve prolapse (MVP) has a prevalence of 2-3% among the population. It involves a heterogeneous group of patients with different expressions and according to the phenotype can be further divided into fibroelastic deficiency, which is mainly considered as a degeneration due to aging, and myxomatous disease, frequently associated with familiar clusters. Thus, MVP can be present in syndromic, when part of a well-defined syndrome, and non-syndromic forms. The latter occurs more often. To the second belong both familiar and isolated or sporadic forms. On one hand, among familial forms, although X-linked transmission related to

Identifiants

pubmed: 35345263
pii: S1530-6550(22)00420-3
doi: 10.31083/j.rcm2303096
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
DZIP1 protein, human 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

96

Informations de copyright

© 2022 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Nicolò Azzola Guicciardi (NA)

Cardiac Surgery, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.
Vita-Salute University, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.

Michele De Bonis (M)

Cardiac Surgery, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.
Vita-Salute University, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.

Chiara Di Resta (C)

Vita-Salute University, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.
Unit of Genomics for Human Disease Diagnosis, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.

Guido Ascione (G)

Cardiac Surgery, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.

Ottavio Alfieri (O)

Cardiac Surgery, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.

Francesco Maisano (F)

Cardiac Surgery, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.
Vita-Salute University, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.

Pasquale Vergara (P)

Arrhythmia Unit and Electrophysiology Laboratories, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH